Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 7:08 AM ET

Pharmaceuticals

Company Overview of Capsugel Inc.

Company Overview

Capsugel Inc. develops dosage forms and solutions for the healthcare industry around the world. It offers gelatin, alternate polymer, and liquid-filled capsules; hard gelatin, sprinkle, plus HPMC, fish gelatin, pearlescent, over-encapsulation, pre-clinical, liquid, soft gelatin, acid-resistant capsules; gelcaps; capsule in capsule technology products; and solid lipid pellet technology products. The company also provides precision powder micro-dosing systems, CFS liquid filling and sealing machines, profill manual capsule filling machines, and commercial scale capsule filling machines. The company develops drug delivery technology platform, enTRinsic, that offers enteric protection without th...

412 Mount Kemble Avenue

Suite 200-C

Morristown, NJ 07960

United States

Founded in 1963

Phone:

862-242-1700

Key Executives for Capsugel Inc.

Chief Executive Officer and President
Chief Financial Officer
Age: 51
Chief Marketing Officer and Senior Vice President
Senior Vice President of Research and Development
Senior Director of Corporate Communications
Compensation as of Fiscal Year 2015.

Capsugel Inc. Key Developments

Capsugel Introduces enTRinsic Drug Delivery Technology Platform

Capsugel has launched its enTRinsic drug delivery technology platform, which offers enteric protection without the requirement of functional coatings. The technology provides targeted release of gastric acid- and heat-sensitive active ingredients to the upper gastrointestinal tract. It allows oral delivery of several compounds, including vaccines, proteins and peptides, using pharmaceutically approved enteric polymers. The technology is now available worldwide for customer projects after the completion of a lead-user customer-collaboration program, which was undertaken in 18 months. The enTRinsic technology further expands Capsugel's range of modified and targeted release solutions, and the company's biotherapeutic formulation offering.

Capsugel and Cardax to Collaborate on Development of Proprietary Astaxanthin Products

Capsugel and Cardax, Inc. announced a collaboration to develop unique astaxanthin products for the consumer health market. The goal of the collaboration is to commercialize proprietary formulations of nature-identical synthetic astaxanthin products with pharmaceutical-grade purity that will provide improved oral bioavailability compared with other astaxanthin products on the market. Astaxanthin is currently used as a specialized antioxidant. The astaxanthin products will be jointly developed using Capsugel's proprietary lipid multi-particulate (LMP) technology, which encapsulates dissolved or suspended active ingredients into spherical lipid matrix particles for oral dosage in capsules, sachets, suspensions or tablets. LMP technology utilizes a range of approved lipids to deliver the benefits of lipid-based formulations in multi-particulate format, including improved bioavailability, controlled release and effective taste-masking. The companies will seek a strategic partner for retail commercialization in the mass market. Specific business terms were not disclosed.

Similar Private Companies By Industry

Company Name Region
Capsugel Inc. United States
Cavion LLC United States
Bedford Laboratories United States
Viamet Pharmaceuticals, Inc. United States
CNS Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 14, 2015
100% in Xcelience, LLC and Remaining Stake in PowderSize, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Capsugel Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.